Insulin sensitivity in the liver and skeletal muscle was improved in SELENOP-deficient mice, while intraperitoneal injection with SELENOP impaired insulin signaling, suggesting that SELENOP is a hepatokine capable of inducing insulin resistance [101,210]. The gene discussed is INS; the disease is Insulin resistance.